Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enhancing race-based prescribing precision with pharmacogenomics.

A Nguyen1, Z Desta, D A Flockhart

  • 1Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA. annnguye@iupui.edu

Clinical Pharmacology and Therapeutics
|March 7, 2007
PubMed
Summary

Race and ethnicity can serve as imperfect biomarkers for predicting drug effects. Combining these with pharmacogenetic markers can improve personalized medicine and optimize drug therapy for individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of disorder-free localization using a (2+1)D lattice gauge theory on a quantum processor.

Science (New York, N.Y.)·2026
Same author

Mapping Real-world Rebiopsy Events to Treatment Trajectories in EGFR/ALK/ROS1-Driven Non-small-cell Lung Cancer: Insights from the AURORA Cohort.

Clinical lung cancer·2026
Same author

Robot-assisted MIS transiliac sacroiliac joint fusion: Technical note.

Neuro-Chirurgie·2025
Same author

Functional Connectivity Is Stronger Between Unisensory and Multisensory Regions for Nonsimultaneous Judgments of Visual-Tactile Stimuli.

Psychophysiology·2025
Same author

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Physical review letters·2025

Area of Science:

  • Pharmacogenomics
  • Medical Biomarkers
  • Drug Response Prediction

Background:

  • Race and ethnicity are often used as proxies for biological differences influencing drug efficacy.
  • Self-reported race is a complex marker, integrating genetic and environmental factors.
  • Current prescribing practices may rely on race as an imperfect predictor of drug response.

Purpose of the Study:

  • To explore the role of race and ethnicity as biomarkers in medicine.
  • To investigate the potential of pharmacogenetic markers to refine race-based prescribing.
  • To advocate for the optimization of individualized therapy through combined predictors.

Main Methods:

  • Review of existing literature on race, ethnicity, and drug response.
  • Analysis of self-reported race as a composite biomarker.

Related Experiment Videos

  • Discussion of pharmacogenetic markers (e.g., haplotypes, genotypes) as precision tools.

    • Main Results:

    • Self-reported race is an imperfect but utilized biomarker for drug effect prediction.
    • Pharmacogenetic markers offer a pathway to enhance the precision of race-based prescribing.
    • Integration of genetic and non-genetic predictors is key for therapy individualization.

    Conclusions:

    • Race and ethnicity can be considered as potential biomarkers in therapeutics.
    • Pharmacogenetic data can augment race-based prescribing for improved accuracy.
    • Optimizing individualized therapy requires a multifaceted approach combining various predictive markers.